BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 8215785)

  • 41. Induction of antigen specific peripheral humoral tolerance to cardiac myosin does not prevent CB3-mediated autoimmune myocarditis.
    Horwitz MS; Ilic A; Fine C; Sarvetnick N
    J Autoimmun; 2005 Sep; 25(2):102-11. PubMed ID: 16011890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antigenic complementarity between coxsackie virus and streptococcus in the induction of rheumatic heart disease and autoimmune myocarditis.
    Root-Bernstein R; Vonck J; Podufaly A
    Autoimmunity; 2009 Jan; 42(1):1-16. PubMed ID: 18608177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis.
    Maisch B; Trostel-Soeder R; Stechemesser E; Berg PA; Kochsiek K
    Clin Exp Immunol; 1982 Jun; 48(3):533-45. PubMed ID: 6288291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Enteroviruses and dilated cardiomyopathies].
    Kopecka H; Bouhour JB; Langlard JM; Petitjean J; Freymuth F
    Pathol Biol (Paris); 1993 Jun; 41(6):521-3. PubMed ID: 8247630
    [No Abstract]   [Full Text] [Related]  

  • 45. Pathophysiology of cardiac inflammation: molecular mechanisms.
    Pankuweit S; Portig I; Maisch B
    Herz; 2002 Nov; 27(7):669-76. PubMed ID: 12439638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coxsackievirus B3 genomes detected by polymerase chain reaction: evidence of latent persistency in the myocardium in experimental murine myocarditis.
    Adachi K; Muraishi A; Seki Y; Yamaki K; Yoshizuka M
    Histol Histopathol; 1996 Jul; 11(3):587-96. PubMed ID: 8839749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis.
    Fohlman J; Pauksen K; Morein B; Bjare U; Ilbäck NG; Friman G
    Scand J Infect Dis Suppl; 1993; 88():103-8. PubMed ID: 8390713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival following myocarditis and myocardial calcification associated with infection by Coxsackie virus B-4.
    Barson WJ; Craenen J; Hosier DM; Brawley RL; Hilty MD
    Pediatrics; 1981 Jul; 68(1):79-81. PubMed ID: 6264379
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenesis of myocardial injury in myocarditis and cardiomyopathy.
    Matsumori A; Okada I; Yamada T; Maruyama S; Kawai C
    Jpn Circ J; 1991 Nov; 55(11):1132-7. PubMed ID: 1660942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The efficacy of taktivin in patients with viral myocarditis and dilated cardiomyopathy].
    Kipshidze NN; Dzhaparidze MM; Dzidziguri LM; Rachvelishvili NB; Dateshidze MN; Demetrashvili MF
    Ter Arkh; 1990; 62(9):116-8. PubMed ID: 2177920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
    Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
    Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The expression of coxsackie B virus adenovirus receptor (CAR) in viral myocarditis and dilated cardiomyopathy patients].
    Li HY; Li YH; Zhu TJ
    Fa Yi Xue Za Zhi; 2007 Aug; 23(4):247-9. PubMed ID: 17896511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy.
    Chapman NM; Kim KS
    Curr Top Microbiol Immunol; 2008; 323():275-92. PubMed ID: 18357775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of sensitized T-cells in myocarditis and dilated cardiomyopathy.
    Schwimmbeck PL; Badorff C; Rohn G; Schulze K; Schultheiss HP
    Int J Cardiol; 1996 May; 54(2):117-25. PubMed ID: 8803675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Viral lesions of the heart as a cause of sudden death].
    Prokhorova IA
    Arkh Patol; 1981; 43(5):78-82. PubMed ID: 7025808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The role of Coxsackie B viruses in the etiology of dilated cardiomyopathy].
    Shirobokov VP; Amosova EN; Korniushenko ON; Evtushenko AI; Krivolap VI
    Ter Arkh; 1990; 62(3):107-10. PubMed ID: 2164261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationship of myocarditis to dilated cardiomyopathy.
    MacArthur CG; Tarin D; Goodwin JF; Hallidie-Smith KA
    Eur Heart J; 1984 Dec; 5(12):1023-35. PubMed ID: 6100098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of enteroviral genome and its significance in cardiomyopathy.
    Katsuragi M; Yutani C; Mukai T; Arai Y; Imakita M; Ishibashi-Ueda H; Hao H; Nagata S; Miyatake K
    Cardiology; 1993; 83(1-2):4-13. PubMed ID: 8261486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of Coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction.
    Weiss LM; Movahed LA; Billingham ME; Cleary ML
    Am J Pathol; 1991 Feb; 138(2):497-503. PubMed ID: 1847008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.